1 |
Etoh T, Shibuta K, Barnard GF, Kitano S, Mori M. Angiogenin expression in human colorectal cancer: the role of focal macrophage infiltration. Clin Cancer Res. 2000. 6: 3545-3551.
|
2 |
Fett JW, Strydom DJ, Lobb RR, Alderman EM, Bethune JL, Riordan JF, Vallee BL. Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 1985. 24: 5480-5486.
DOI
ScienceOn
|
3 |
Kao RY, Jenkins JL, Olson KA, Key ME, Fett JW, Shapiro R. A small-molecule inhibitor of the ribonucleolytic activity of human angiogenin that possesses antitumor activity. Proc Natl Acad Sci USA. 2002. 99: 10066-10071.
DOI
ScienceOn
|
4 |
Kim JK, Shin EK, Park JH, Kim YH, Park JH. Antitumor and antimetastatic effects of licochalcone A in mouse models. J Mol Med. 2010a. 88: 829-838.
DOI
ScienceOn
|
5 |
Kim YH, Shin EK, Kim DH, Lee HH, Park JH, Kim JK. Antiangiogenic effect of licochalcone A. Biochem Pharmacol. 2010b. 80: 1152-1159.
DOI
ScienceOn
|
6 |
Montero S, Guzman C, Cortes FH, Colomer R. Angiogenin expression and prognosis in primary breast carcinoma. Clin Cancer Res. 1998. 4: 2161-2168.
|
7 |
Olson KA, Byers HR, Key ME, Fett JW. Prevention of human prostate tumor metastasis in athymic mice by antisense targeting of human angiogenin. Clin Cancer Res. 2001. 7: 3598-3605.
|
8 |
Shimoyama S, Gansauge F, Gansauge S, Negri G, Oohara T, Beger HG. Increased angiogenin expression in pancreatic cancer is related to cancer aggressiveness. Cancer Res. 1996. 56: 2703 -2706.
|
9 |
Tello-Montoliu A, Patel JV, Lip GY. Angiogenin: a review of the pathophysiology and potential clinical applications. J Thromb Haemost. 2006. 4: 1864-1874.
DOI
ScienceOn
|
10 |
Adams SA, Subramanian V. The angiogenins: an emerging family of ribonuclease related proteins with diverse cellular functions. Angiogenesis 1999. 3: 189-199.
DOI
ScienceOn
|